MedTrace Logo

Exploring Buckwheat's Glucose Lowering Potential

NCT00841503 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2012-03-21

No results posted yet for this study

Summary

Bioactive components in buckwheat enhance insulin sensitivity in Type 2 diabetes by improving glucose uptake and utilization through a unique mechanism that operates independent of insulin.

Conditions

Interventions

OTHER

buckwheat, rice crackers, glucose, sugar substitute

crackers contain equal amounts of available carbohydrates; 50 mls of oral solution for both glucose and Splenda

Sponsors & Collaborators

  • University of Manitoba

    collaborator OTHER

  • St. Boniface Hospital

    lead OTHER

Principal Investigators

  • Peter C Zahradka, PhD · Canadian Centre for Agri-Food Research in Health & Medicine

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00841503 on ClinicalTrials.gov